Gout and risk for subsequent coronary heart disease - The Meharry-Hopkins study

被引:63
作者
Gelber, AC
Klag, MJ
Mead, LA
Thomas, J
Thomas, DJ
Pearson, TA
Hochberg, MC
机构
[1] JOHNS HOPKINS MED INST, DEPT MED, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS MED INST, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA
[3] MEHARRY MED COLL, DEPT MED, NASHVILLE, TN 37208 USA
[4] MARY IMOGENE BASSETT RES INST, COOPERSTOWN, NY USA
[5] UNIV MARYLAND, SCH MED, DEPT MED, BALTIMORE, MD 21201 USA
[6] UNIV MARYLAND, SCH MED, DEPT EPIDEMIOL, BALTIMORE, MD 21201 USA
[7] UNIV MARYLAND, SCH MED, DEPT PREVENT MED, BALTIMORE, MD 21201 USA
[8] VET AFFAIRS MED CTR, GERIATR RES EDUC & CLIN CTR, BALTIMORE, MD USA
关键词
D O I
10.1001/archinte.157.13.1436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with gout are encountered frequently in clinical practice. Previous studies have suggested that hyperuricemia and gout ma) represent risk factors for coronary heart disease (CHD), the most common cause of death in American men. Methods: Prospectively collected data from 2 longitudinal cohort studies of former medical students-371 black men in the Meharry Cohort Study and 1181 white men in the Johns Hopkins Precursors Study-were analyzed. The development of gout and of CHD was determined by physician self-report, and validated by using published criteria. The risk for CHD associated with gout was evaluated using Cox proportional hazards analysis. Results: During a median follow-up of 30 years, there were 38 gout cases and 43 CHD events among the Meharry men, and 68 gout cases and 138 CHD events among the Hopkins men. Prior gout was not associated with an increased risk for incident CI-ID (relative risk=1.20; 95% confidence interval, 0.37-3.92) among the Meharry men or among the Hopkins men (relative risk=0.66; 95% confidence interval. 0.24-1.79). Multivariate analysis adjusted for known CHD risk factors did not alter these findings. Conclusion: These results, in black and white male physicians, do not suggest a role in men for targeting gout identification in the primary prevention of CHD.
引用
收藏
页码:1436 / 1440
页数:5
相关论文
共 23 条
[1]   GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
ABBOTT, RD ;
BRAND, FN ;
KANNEL, WB ;
CASTELLI, WP .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) :237-242
[2]   HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   RELATION OF SERUM URIC-ACID TO MORTALITY AND ISCHEMIC-HEART-DISEASE - THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY [J].
FREEDMAN, DS ;
WILLIAMSON, DF ;
GUNTER, EW ;
BYERS, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) :637-644
[6]   SERUM URIC ACID IN RELATION TO AGE AND PHYSIQUE IN HEALTH AND IN CORONARY HEART DISEASE [J].
GERTLER, MM ;
GARN, SM ;
LEVINE, SA .
ANNALS OF INTERNAL MEDICINE, 1951, 34 (06) :1421-1431
[7]   RELEASE OF PLATELET CONSTITUENTS BY MONOSODIUM URATE CRYSTALS [J].
GINSBERG, MH ;
KOZIN, F ;
OMALLEY, M ;
MCCARTY, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05) :999-1007
[8]   SERUM URIC-ACID - CORRELATION WITH BIOCHEMICAL, ANTHROPOMETRIC, CLINICAL AND BEHAVIORAL PARAMETERS IN 10,000 ISRAELI MEN [J].
GOLDBOURT, U ;
MEDALIE, JH ;
HERMAN, JB ;
NEUFELD, HN .
JOURNAL OF CHRONIC DISEASES, 1980, 33 (07) :435-443
[9]   RACIAL-DIFFERENCES IN THE INCIDENCE OF GOUT - THE ROLE OF HYPERTENSION [J].
HOCHBERG, MC ;
THOMAS, J ;
THOMAS, DJ ;
MEAD, L ;
LEVINE, DM ;
KLAG, MJ .
ARTHRITIS AND RHEUMATISM, 1995, 38 (05) :628-632
[10]   SERUM-CHOLESTEROL IN YOUNG MEN AND SUBSEQUENT CARDIOVASCULAR-DISEASE [J].
KLAG, MJ ;
FORD, DE ;
MEAD, LA ;
HE, J ;
WHELTON, PK ;
LIANG, KY ;
LEVINE, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05) :313-318